Generic Drugmakers Fight Teva’s Bid to Stall Competition
Generic Drugmakers Fight Teva’s Bid to Stall Competition Wall St Cheat Sheet
View ArticleTeva Rejected by Supreme Court on Generic Copaxone Delay
Teva Rejected by Supreme Court on Generic Copaxone Delay Bloomberg
View ArticleSanofi's MS team rebuilds its case for the FDA-rejected MS drug Lemtrada
Sanofi's MS team rebuilds its case for the FDA-rejected MS drug Lemtrada Fierce Biotech
View ArticleInovio acquires early stage DNA therapies to treat Alzheimer's, MS
Inovio acquires early stage DNA therapies to treat Alzheimer's, MS The Fly on the Wall
View ArticleTeva Loses Suit Against FDA Over Generic of Copaxone
Teva Loses Suit Against FDA Over Generic of Copaxone Bloomberg
View ArticleTeva, Active Biotech to continue development of Nerventra
Teva, Active Biotech to continue development of Nerventra The Fly on the Wall
View ArticleGeneric Copaxone approval very unlikely this quarter, says Jefferies
Generic Copaxone approval very unlikely this quarter, says Jefferies The Fly on the Wall
View Article[video]Supreme Court + Risky Drug Launch = Billions at Stake
[video]Supreme Court + Risky Drug Launch = Billions at Stake Motley Fool
View ArticleSurprising Drug Approval: Time to Buy? (video)
Surprising Drug Approval: Time to Buy? (video) Motley Fool
View ArticleIPO Stock Watch: Receptos Soars On MS Drug Results
IPO Stock Watch: Receptos Soars On MS Drug Results Investors.com
View ArticleBiogen, AbbVie drug slows MS episodes, safety issues recur
Biogen, AbbVie drug slows MS episodes, safety issues recur Yahoo/Reuters
View ArticleBiogen, AbbVie drug slows MS episodes, safety issues recur
Biogen, AbbVie drug slows MS episodes, safety issues recur Yahoo/Reuters
View ArticleWhy Teva's Magic Bullet Could Misfire
Why Teva's Magic Bullet Could Misfire Motley Fool
View ArticleTeva files petition with U.S. FDA against MS drug competitors
Teva files petition with U.S. FDA against MS drug competitors Yahoo/Reuters
View ArticleFDA's Looming Decision On A Generic To Teva's Copaxone Reveals Drug Approval...
FDA's Looming Decision On A Generic To Teva's Copaxone Reveals Drug Approval Woes Forbes
View ArticleAlkermes takes its Tecfidera beater into clinical trials for MS
Alkermes takes its Tecfidera beater into clinical trials for MS Fierce Biotech
View ArticleCould This 1 Lawsuit Destroy Biogen Idec Stock?
Could This 1 Lawsuit Destroy Biogen Idec Stock? Motley Fool
View ArticleTeva gets more than half of U.S. Copaxone patients converted to long-lasting...
Teva gets more than half of U.S. Copaxone patients converted to long-lasting version Fierce Pharma
View ArticleTeva eyes 'hard switch' to hit Copaxone goals if the soft sell isn't enough
Teva eyes 'hard switch' to hit Copaxone goals if the soft sell isn't enough Fierce Pharma Marketing
View Article
